: BPC-157 Futupeptide Blend (L-, L- , L-, L-, L- HCL, L-, L- HCL, L-, L-, L-, L- HCL, L-, L-, L-, L-), (HPMC
"I have said throughout this process that you do not solve a quality problem by forcing the market underground." "I was encouraged by the committees recommendation because it creates an opportunity to move patients away from unverified research use only (RUO), otherwise known as grey market products, and toward a more accountable medical pathway." LaValle said his work with the International Peptide Society focuses on training clinicians about the potential benefits and risks of peptide therapies as interest in the compounds grows
Like Ive had that conversation a couple times
Making an informed decision can help you achieve effective and safe results